Keywords: Amgen, Micromet, M&A, BiTE antibodies, Leukemia, Non-Hodgkin's lymphoma

Amgen to acquire US/German biotech firm

Article | 27 January 2012

Print This

Adding to the strong start this year for M&A activity in the Pharma/Biotech sector, USA-based Amgen (Nasdaq: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in